Objectives: Describe the histopathology of the temporal bones in MELAS (myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) syndrome. The syndrome results from a known point mutation in mitochondrial DNA.
| INTRODUCTION
Hearing loss is common, and genetic abnormalities are a frequent cause. Mutations in mitochondrial DNA (mtDNA) are responsible for close to 1% of prelingual congenital deafness and approximately 5% of post lingual hearing loss in Caucasians. 1 Mutations in mtDNA can cause both syndromic and isolated hearing loss.
MELAS is a syndrome typified by mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes. 2 Although a number of mutations can cause the syndrome, the majority (80%) are caused by a point mutation of alanine and guanine at 3243. 3 MELAS syndrome is the most common maternally inherited mitochondrial disease.
The goal of this article is to describe the histopathology of the temporal bones, in a patient with MELAS syndrome, and discuss the broader implications on mitochondrial hearing loss. The mtDNA is 16 568 bp long, double stranded, circular, and transcribed from both the guanine-rich heavy (H) strand and the cytosine rich light (L) strand, encoding 22 tRNAs, 2 rRNAs, and 13 mRNAs.
Mitochondrial genes are located close to each other (37 genes on 16.5kb). The mtDNA has no introns, and only a small noncoding region. 6 As all protein-encoding mitochondrial genes encode proteins involved in oxidative phosphorylation, all diseases caused by mutations in the mitochondrial genome are characterized by defective oxidative phosphorylation. In most cases, this leads to multisystem disorders, but some mitochondrial diseases can cause dysfunction in one organ, often the cochlea. 1 In addition some mitochondrial proteins are encoded by nuclear DNA. The nuclear genes encoding mitochondrial proteins are involved in all mitochondrial functions mentioned, and the expression of mt DNA itself. Therefore, the spectrum of mitochondrial genetic diseases caused by inherited mutations in nuclear genes is broad.
Given the significant energy consumption of the cochlea, mitochondrial disease can cause syndromic or isolated hearing loss. The prevalence of mtDNA-related deafness is less than 1% of patients with congenital deafness but is close to 5% in Caucasians with postlingual deafness. MELAS is a syndrome typified by mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes. Hearing loss is present in 30%-75% of patients with MELAS syndrome. 8 It typically presents before the age of 40 and can vary from mild loss to severe loss meeting the criteria for cochlear implantation.
About 20% of patients with MELAS syndrome have severe to profound sensorineural hearing loss. Hearing loss is symmetric, commonly starts at the high tones progressing to involve the mid-and low tones.
However, it can be the same across frequencies. Hearing loss can be the first and initially the only manifestation of MELAS syndrome. The diagnosis of a mitochondrial cause for hearing loss can have several clinical implications such as avoidance of exposure to noise and aminoglycosides. In the case presented hearing loss was the sole symptom of MELAS syndrome for more than a decade. In a family with no history of either hearing loss or mitochondrial disease, a patient with such long duration of deafness is unlikely to be identified with mitochondrial deafness. The patient died at the age of 42 years.
Previous descriptions of temporal bone histopathology are of patients who died at the age of 23 and 30 years, making the reported case the oldest one with MELAS syndrome.
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The main histopathology finding in the studied case is severe atrophy of the stria vascularis in both cochleae with preservation of the organ of Corti and most spiral ganglion neurons. Spiral ganglion population exceeded 50% of the normal age-matched complement even in the worse hearing right ear. By itself, this level of neuronal population usually is not associated with pure-tone thresholds shifts.
These observations were seen in two previously reported temporal bones. 
